Rua Bioscience Limited (RUA.NZ)
NZD 0.03
(0.0%)
NZD 0.03
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 147.78 Thousand NZD | 28.98% |
| 2023 | 114.57 Thousand NZD | -86.1% |
| 2022 | 824 Thousand NZD | -39.78% |
| 2021 | 1.36 Million NZD | 292.27% |
| 2020 | 348.79 Thousand NZD | 60.88% |
| 2019 | 216.8 Thousand NZD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 FY | 147.78 Thousand NZD | 28.98% |
| 2024 Q1 | 124.02 Thousand NZD | 8.25% |
| 2024 Q4 | 147.78 Thousand NZD | 0.0% |
| 2024 Q2 | 167.68 Thousand NZD | 35.2% |
| 2023 Q3 | 67.85 Thousand NZD | -67.5% |
| 2023 Q1 | 123.03 Thousand NZD | -85.07% |
| 2023 Q4 | 114.57 Thousand NZD | 68.86% |
| 2023 FY | 114.57 Thousand NZD | -86.1% |
| 2023 Q2 | 208.75 Thousand NZD | 69.68% |
| 2022 Q1 | 750.9 Thousand NZD | -45.12% |
| 2022 FY | 824 Thousand NZD | -39.78% |
| 2022 Q4 | 824 Thousand NZD | 18.48% |
| 2022 Q3 | 695.45 Thousand NZD | -23.15% |
| 2022 Q2 | 904.95 Thousand NZD | 20.51% |
| 2021 Q1 | 220.22 Thousand NZD | -36.86% |
| 2021 Q3 | 820.88 Thousand NZD | 165.04% |
| 2021 Q4 | 1.36 Million NZD | 66.68% |
| 2021 Q2 | 309.71 Thousand NZD | 40.63% |
| 2021 FY | 1.36 Million NZD | 292.27% |
| 2020 FY | 348.79 Thousand NZD | 60.88% |
| 2020 Q4 | 348.79 Thousand NZD | 3140.98% |
| 2020 Q3 | 10.76 Thousand NZD | 0.0% |
| 2020 Q1 | - NZD | 0.0% |
| 2019 FY | 216.8 Thousand NZD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AFT Pharmaceuticals Limited | 32.18 Million NZD | 99.541% |
| Greenfern Industries Limited | 854.24 Thousand NZD | 82.701% |